[go: up one dir, main page]

NO870512L - 1,4-benzoksazinderivater og fremgangsmaate for deres fremstilling. - Google Patents

1,4-benzoksazinderivater og fremgangsmaate for deres fremstilling.

Info

Publication number
NO870512L
NO870512L NO870512A NO870512A NO870512L NO 870512 L NO870512 L NO 870512L NO 870512 A NO870512 A NO 870512A NO 870512 A NO870512 A NO 870512A NO 870512 L NO870512 L NO 870512L
Authority
NO
Norway
Prior art keywords
benzocsazine
procedures
derivatives
preparation
benzocsazine derivatives
Prior art date
Application number
NO870512A
Other languages
English (en)
Other versions
NO870512D0 (no
Inventor
Kanji Meguro
Kohei Nishikawa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO870512D0 publication Critical patent/NO870512D0/no
Publication of NO870512L publication Critical patent/NO870512L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO870512A 1986-02-11 1987-02-10 1,4-benzoksazinderivater og fremgangsmaate for deres fremstilling. NO870512L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2872086 1986-02-11
JP8750386 1986-04-15

Publications (2)

Publication Number Publication Date
NO870512D0 NO870512D0 (no) 1987-02-10
NO870512L true NO870512L (no) 1987-08-12

Family

ID=26366867

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870512A NO870512L (no) 1986-02-11 1987-02-10 1,4-benzoksazinderivater og fremgangsmaate for deres fremstilling.

Country Status (10)

Country Link
US (1) US4789675A (no)
EP (1) EP0233728A1 (no)
KR (1) KR870007927A (no)
CN (1) CN87100658A (no)
AU (1) AU6853187A (no)
CA (1) CA1289957C (no)
DK (1) DK65987A (no)
FI (1) FI870546A7 (no)
HU (1) HUT47103A (no)
NO (1) NO870512L (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4857526A (en) * 1986-03-05 1989-08-15 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)-one-1,1-dioxide
US4920118A (en) * 1986-03-05 1990-04-24 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3-(2H)one-1,1-dioxide and their use as anxiolytic and anti-hypertensive agents
GB8803419D0 (en) * 1988-02-15 1988-03-16 Erba Carlo Spa 1 4-benzoxazine & 1 4-benzothiazine derivatives & process for their preparation
US5229383A (en) * 1988-02-15 1993-07-20 Farmitalia Carlo Erba S.R.L. Piperazine-substituted 1,4-benzoxazine derivatives and their use in treating disorders of the central nervous system
CA1321751C (en) * 1989-02-21 1993-08-31 Eugene C. Crichlow Mechanism mediating ruminal stasis in ruminal lactic acidosis
HU214591B (hu) * 1989-12-14 1998-04-28 Novartis Ag. Eljárás egy naftoxazinszármazék malonátsójának és az ilyen hatóanyagot tartalmazó gyógyszerkészítmények előállítására
US5215987A (en) * 1990-04-23 1993-06-01 Ortho Pharmaceutical Corporation Substituted benzhydryl 2-hydroxypropyl piperazine derivatives
JP2939646B2 (ja) * 1990-07-17 1999-08-25 チッソ株式会社 ４―置換―２―ヒドロキシブタン酸エステルおよび製造法
US5332733A (en) * 1990-11-24 1994-07-26 Kali-Chemie Pharma Gmbh Heterocyclically substituted piperazinoakylbenzoxazine and piperazinoalkylbenzothiazine compounds, processes for preparing them, and medicaments containing them
DE4037426A1 (de) * 1990-11-24 1992-05-27 Kali Chemie Pharma Gmbh Piperidinoalkylbenzoxazin- und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4037427A1 (de) * 1990-11-24 1992-05-27 Kali Chemie Pharma Gmbh Heterocyclisch substituierte piperazinoalkylbenzoxazin und -thiazin-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FR2680172B1 (fr) * 1991-08-05 1993-11-19 Fabre Medicament Pierre Nouvelles piperazinylalcoyl-3 dihydro-2,3 4h-benzoxazine-1,3 ones-4 substituees, leur preparation et leur application en therapeutique.
US5696117A (en) * 1995-11-07 1997-12-09 Ortho Pharmaceutical Corporation Benzoxazine antimicrobial agents
US5707990A (en) * 1996-01-30 1998-01-13 Ortho Pharmaceutical Corporation 2-substituted amino and thio alkyl benzoxazine antimicrobial agents
US6177422B1 (en) 1996-05-29 2001-01-23 Warner-Lambert Company Benzoxazinone dopamine D4 receptor antagonists
ES2191180T3 (es) * 1996-05-29 2003-09-01 Warner Lambert Co Antagonistas de los receptores de la dopamina benzoxazinona d4.
DK0985414T3 (da) * 1998-05-26 2003-12-29 Pfizer Prod Inc Lægemiddel til behandling af glaukome og iskæmisk retinopati
CN100486574C (zh) * 1999-12-21 2009-05-13 田边三菱制药株式会社 用于神经系统疾病的治疗和/或预防药物
WO2009111700A2 (en) * 2008-03-07 2009-09-11 Transtech Pharma, Inc. Oxadiazoanthracene compounds for the treatment of diabetes
BRPI1013579A2 (pt) * 2009-03-30 2020-11-03 Transtech Pharma, Inc. derivados de azoantraceno substituídos, composições farmacêuticas e métodos de uso dos mesmos
WO2011031620A1 (en) * 2009-09-11 2011-03-17 Transtech Pharma, Inc. Solid compositions comprising an oxadiazoanthracene compound and methods of making and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3401166A (en) * 1966-08-01 1968-09-10 Squibb & Sons Inc Therapeutically active benzothiazines
GB2080791B (en) * 1980-06-19 1984-02-22 Erba Farmitalia 1,4-benzoxazines
US4613598A (en) * 1984-03-13 1986-09-23 Mitsubishi Chemical Industries Limited Piperazine derivatives and their acid addition salts
GB8419797D0 (en) * 1984-08-03 1984-09-05 Beecham Group Plc Compounds
EP0186310A1 (en) * 1984-11-28 1986-07-02 Takeda Chemical Industries, Ltd. 1,4-Benzothiazine Derivatives, their production and use
US4704390A (en) * 1986-02-13 1987-11-03 Warner-Lambert Company Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents

Also Published As

Publication number Publication date
FI870546A0 (fi) 1987-02-10
FI870546A7 (fi) 1987-08-12
US4789675A (en) 1988-12-06
CN87100658A (zh) 1987-09-09
EP0233728A1 (en) 1987-08-26
DK65987D0 (da) 1987-02-10
DK65987A (da) 1987-08-12
KR870007927A (ko) 1987-09-22
NO870512D0 (no) 1987-02-10
AU6853187A (en) 1987-08-13
HUT47103A (en) 1989-01-30
CA1289957C (en) 1991-10-01

Similar Documents

Publication Publication Date Title
NO882390D0 (no) (ih-azol-1-ylmetyl)substituerte benzotriazolderivater og deres fremstilling.
DK462187D0 (da) Pyridinyl-pyrimidin-derivater, deres fremstilling og anvendelse.
NO870512D0 (no) 1,4-benzoksazinderivater og fremgangsmaate for deres fremstilling.
NO875358L (no) 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner og fremgangsmaate for deres fremstilling.
NO892745D0 (no) Aminoalkylaminokarbonylaminodiolaminosyrederivater og fremgangsmaate for deres fremstilling.
NO871526L (no) Tiolaktam-n-eddiksyrederivater og fremgangsmaate for deres fremstilling.
NO871052L (no) 1,1-disubstituerte cyklopropanderivater, fremgangsmaate til deres fremstilling og deres anvendelse.
NO903169L (no) 4,1,2-1h-benzoksadiaziner og deres fremstilling.
DK193088A (da) 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse
DK633287A (da) Carbamoylimidazo-derivater, deres fremstilling og anvendelse
DK235787A (da) Tripeptidderivater, deres fremstilling og anvendelse
NO164652C (no) Polyfluoralkyltiometyl forbindelser, deres fremstilling og anvendelse.
NO883114D0 (no) 1h-pyrazol-1-alkanamider og fremgangsmaate for deres fremstilling.
NO872625D0 (no) Benzimidazoler og fremgangsmaater for deres fremstilling.
DK213387D0 (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK189488D0 (da) Imidazothiadiazinderivater, deres fremstilling og anvendelse
DK212687A (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
NO865004L (no) Nye 16,17-acetalsubstituerte pregnan-21-oinsyrederivater og fremgangsmaate for deres fremstilling.
DK607787D0 (da) 12-halogenerede forskolin-derivater, deres fremstilling og anvendelse
NO893565D0 (no) Etansulfonamidderivater og fremgangsmaate for deres fremstilling.
DK610787D0 (da) Substituerede thienoimidazoltoluidin-derivater, deres fremstilling og anvendelse
NO872885L (no) 1,3,5-tritianderivater og fremgangsmŸte for deres fremstilling.
DK14987D0 (da) Fluorerede deaminoalkylderivater, deres fremstilling og anvendelse
NO894697D0 (no) Penemderivater og fremgangsmaater for deres fremstilling.
NO885020D0 (no) Isokinolinderivater, deres fremstilling og anvendelse.